X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/mabwell-releases-preclinical-study-results-of-multiple-innovative-drugs-released-at-the-2024-aacr-annual-meeting-302117739.html
https://www.prnewswire.com/news-releases/maiweijian-first-approved-biosimilar-of-denosumab-120mg-in-china-302110441.html
https://www.prnewswire.com/news-releases/mabwell-presented-iddc-platform-technology-and-adc-drug-development-achievements-at-the-14th-world-adc-london-302095573.html
https://www.prnewswire.com/news-releases/sgo-2024--the-first-published-clinical-data-of-nectin-4-targeting-adc-developed-by-mabwell-in-cervical-cancer-demonstrates-its-outstanding-therapeutic-potential-302092792.html
https://www.prnewswire.com/news-releases/mabwell-to-present-pre-clinical-results-at-the-2024-american-association-for-cancer-research-aacr-annual-meeting-302086697.html
https://www.prnewswire.com/news-releases/mabwell-to-present-adc-platform-iddc-and-the-latest-study-results-of-multiple-novel-adcs-at-the-14th-world-adc-london-302085162.html
https://www.prnewswire.com/news-releases/mabwell-to-present-the-clinical-data-of-9mw2821-in-cervical-cancer-as-focused-plenary-oral-presentation-at-2024-society-of-gynecologic-oncology-annual-meeting-on-womens-cancer-302084123.html
https://www.prnewswire.com/news-releases/mabwell-publishes-the-phase-iii-study-results-on-its-denosumab-biosimilar-mw032-in-the-journal-jama-oncology-302067161.html
https://www.prnewswire.com/news-releases/mabwell-receives-ind-approval-from-fda-for-novel-b7-h3-adc-7mw3711-302065758.html
https://www.prnewswire.com/news-releases/new-drug-application-of-mabwells-8mw0511-for-injection-accepted-by-nmpa-302018710.html
Market Place
Share 
